Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy

@article{Salvatore2015SexualFA,
  title={Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy},
  author={Stefano Salvatore and Rossella Elena Nappi and Marta Parma and R. Chionna and Fiorenza Lagona and Nicola Zerbinati and Simone Ferrero and Massimo Origoni and Massimo Candiani and Umberto Leone Roberti Maggiore},
  journal={Climacteric},
  year={2015},
  volume={18},
  pages={219 - 225}
}
Abstract Objective To investigate the effects of fractional microablative CO2 laser on sexual function and overall satisfaction with sexual life in postmenopausal women with vulvovaginal atrophy (VVA). Method This prospective study included 77 postmenopausal women (mean age 60.6 ± 6.2 years) treated for VVA symptoms with the fractional microablative CO2 laser system (SmartXide2 V2LR, Monalisa Touch, DEKA, Florence, Italy). Sexual function and quality of life were evaluated with the Female… Expand

Paper Mentions

Interventional Clinical Trial
Women with genitourinary syndrome of menopause, overactive bladder, with breast or endometrial cancer are randomized to either laser treatment og sham treatment for 3 months. The… Expand
ConditionsBladder, Overactive, Breast Cancer, Endometrial Cancer, (+3 more)
InterventionDevice, Procedure
Interventional Clinical Trial
Vulvodynia is a debilitating chronic vulvar pain lasting at least 3 months without a clear identifiable cause that is challenging to treat effectively. Vulvodynia is a common pain… Expand
ConditionsVestibulodynia
InterventionDevice
Interventional Clinical Trial
The CO2RE laser system is a fractional CO2 laser that is FDA approved under a 510(k) K101321 for dermatologic procedures requiring ablation and coagulation of soft tissues, including… Expand
ConditionsVaginal Atrophy
InterventionDevice
Interventional Clinical Trial
The study will examine the effects of fractional/pixel CO2 laser treatment in vaginal atrophy and in vulvar lichen sclerosus by means of histological and immuno-histochemical… Expand
ConditionsLichen Sclerosus, Vaginal Atrophy
InterventionDevice
Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women
TLDR
This study shows that CO2 laser treatment induces a significant and long-lasting improvement of symptoms and this improvement was long lasting. Expand
Fractional CO2 Laser for Treatment of Vulvovaginal Atrophy: A Short Time Follow-up
TLDR
It seems vaginal fractional CO2 laser can be applied as an effective and safe treatment method in genitourinary syndrome of menopause (GSM), it is necessary to conduct studies with long-term follow-up. Expand
Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study
TLDR
Patients receiving vaginal laser had improvement in VVA symptoms and sexual function and further randomised sham-controlled trials are needed to further assess this treatment. Expand
Early effect of fractional CO2 laser treatment in Post-menopausal women with vaginal atrophy.
TLDR
CO2 laser therapy for post-menopausal women can be considered an effective therapeutic option providing relief of symptoms already noted after one laser treatment, and almost all VVA symptoms were significantly improved at one month following the first treatment. Expand
Fractional CO 2 laser versus promestriene and lubricant in genitourinary syndrome of menopause : a randomized clinical trial
Co Abstract Objective: The aim of this study was to compare the effects of fractional CO2 laser therapy, promestriene, and vaginal lubricants on genitourinary syndrome treatment and sexual functionExpand
The effects of fractional microablative CO2 laser therapy on sexual function in postmenopausal women and women with a history of breast cancer treated with endocrine therapy
  • P. Gittens, G. Mullen
  • Medicine
  • Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
  • 2019
TLDR
Fractional microablative CO2 laser therapy (MonaLisa Touch, DEKA) is an effective modality in treating the symptoms of GSM in postmenopausal women and women with a history of breast cancer treated with endocrine therapy. Expand
Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study.
TLDR
Fractional CO2 laser for treatment of VVA seems a safe therapeutic option, and patients were highly satisfied, and they would repeat laser treatment. Expand
Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: An observational study.
TLDR
It is suggested that intravaginal CO2-laser therapy for postmenopausal women with clinical signs and symptoms of GSM may be effective in improving both vaginal pathophysiology and reported symptoms. Expand
Fractional CO laser versus promestriene and lubricant in genitourinary
Received Dec From the Dep Sciences, Sta Paulo, Brazil. Funding/suppo Financial disc Clinical Trial Ethics Commi number (CAA the Brazil Pla UTN identifie Address corre Obstetrics and Campinas, SaExpand
Treatment for vaginal atrophy using microablative fractional CO2 laser: a randomized double-blinded sham-controlled trial.
TLDR
This study demonstrated that the application of microablative fractional CO2 laser was effective in treating vaginal atrophy, and could be a promising alternative treatment for postmenopausal women with vaginalatrophy. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study
TLDR
A 12-week treatment with the fractional CO2 laser was feasible and induced a significant improvement of VVA symptoms by ameliorating vaginal health in postmenopausal women. Expand
Periurethral injection of polyacrylamide hydrogel for the treatment of stress urinary incontinence: the impact on female sexual function.
TLDR
The total PISQ-12 scores showed a significant improvement in quality of sexual life of patients who were sexually active before surgery, indicating periurethral injections of polyacrylamide hydrogel to treat USI are clinically effective and safe. Expand
Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause
  • R. Nappi, S. Palacios
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2014
TLDR
It is essential to overcome the vaginal ‘taboo’ in order to optimize elderly women's health care and include VVA in the menopause agenda, by encouraging an open and sensible conversation on the topic of intimacy and performing a gynecological pelvic examination. Expand
Prevalence and impact of vaginal symptoms among postmenopausal women.
TLDR
The prevalence and perceived severity of VVA symptoms were substantial but less frequent in nonsexually active women and analysis of MHT use by past or current hormone use indicated a trend away from oral dosing and towards patch or vaginal hormones. Expand
Ablative fractionated CO2, laser resurfacing for the neck: prospective study and review of the literature.
TLDR
AFP was both safe and effective for the treatment of neck laxity, rhytids and skin texture and the degree of improvement observed in wrinkling, texture and laxity after AFP coupled with the benign side effect profile has not been reported with previous trials of ablative laser resurfacing of the neck. Expand
Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial.
TLDR
Treatment of postmenopausal women with symptoms of vaginal atrophy with polyacrylic acid, testosterone, and estrogen for 12 weeks produced improvements in self-reported female sexual function when compared with a placebo lubricant. Expand
Fractional laser resurfacing for acne scars: a review
TLDR
This review investigates the effectiveness of ablative and nonablative fractional photothermolysis (FP) lasers for treating facial acne scars and finds that a higher proportion of patients who underwent ablative FP experienced postinflammatory hyperpigmentation (PIH) than those who hadNonablative FP. Expand
Use of the Italian translation of the Female Sexual Function Index (FSFI) in routine gynecological practice
  • R. Nappi, F. Albani, +5 authors F. Polatti
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2008
TLDR
The FSFI is a powerful screening tool for FSD, especially in young fertile women, and may be used effectively in routine gynecological practice. Expand
Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach
TLDR
The most bothersome symptom approach represents a meaningful new standard for measurement of self-assessed vulvovaginal atrophy symptom change, but evaluation of change in individual symptoms remains an important, unbiased primary analysis of efficacy in vulvous atrophy studies. Expand
...
1
2
3
4
5
...